Skip to main content
. 2022 Jul 1;6(13):3861–3869. doi: 10.1182/bloodadvances.2021005684

Table 2.

Age at onset and G-CSF treatment

Congenital Cyclic Autoimmune/Idiopathic
Age, yr <18 ≥18 <18 ≥18 <18 ≥18
Age at presentation, yr Median 0.2 0.4 0.5 4.1 1.1 25.0
Mean 0.9 3.4 1.2 12.6 1.9 27.8
Range (0-15.2) (0-69.6) (0-10.3) (0-74.6) (0-15.6) (0-86.9)
Age at diagnosis, yr Median 0.5 1.1 1.3 11.1 1.4 28.7
Mean 1.2 4.9 2.2 16.6 2.3 30.8
Range (0-14.5) (0-69.7) (0-11.5) (0-74.6) (0-15.9) (0-87.0)
Age at start of G-CSF treatment, yr Median 0.9 7.4 1.6 21.4 1.7 33.3
Mean 2.2 11.1 2.6 24.4 2.8 35.1
Range (0-15.2) (0-74.3) (0.03-10.8) (0.1-74.6) (0.02-16.1) (0.1-87.5)
Age at enrollment, yr Median 2.3 12.8 2.4 25.7 2.2 35.7
Mean 3.7 15.4 3.5 28.1 3.5 36.8
Range (0.1-17.7) (0.2-74.5) (0.4-14.6) (1.1-75.4) (0.4-16.7) (1.0-87.5)